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The genomes of positive strand RNA viruses often contain more than one open 
reading frame. Some of these viruses have evolved novel mechanisms to regulate 
the synthesis of the other open reading frames that in some cases involved the 
production of a subgenomic RNA or RNAs. Very often, the presence of the subge-
nomic RNA is used as indicator for active viral genome replication. Norovirus, a 
major cause for gastroenteritis as well as with all other caliciviruses follow a typical 
positive strand RNA viruses genome replication strategy. In addition, noroviruses 
also produce a subgenomic RNA during their replication in infected cells. Efficient 
and adequate synthesis of norovirus subgenomic RNA is crucial for successful 
viral replication and productive infection leading to the generation of infectious 
viral progeny. This chapter will dissect the significant findings on mechanisms 
involved in norovirus genome replication as well as focusing on subgenomic RNA 
production.
Keywords: RNA-dependent RNA polymerase, subgenomic RNA, replication, 
internal initiation, core promoter
1. Introduction
Noroviruses are often associated with outbreaks of gastroenteritis in hospitals, 
on cruise ships, schools, nursing homes and military camps where a close person 
to person contact cannot be avoided [1]. Infection is typically followed by a 24 to 
48 hour incubation period before emergence of the clinical disease, symptoms 
of which include acute diarrhea and projectile vomiting, usually accompanied by 
several signs/symptoms such as abdominal cramps, myalgia, malaise, headache, 
nausea and low grade fever [2, 3]. Noroviruses are the most common cause of 
gastroenteritis infections due to their stability, low infectious dose, large host 
reservoir (humans), short term immunity, multiple transmission routes and large 
genetic diversity between strain [4]. The human norovirus (HuNv) infection is self-
limiting and the symptoms typically last between 12 and 60 hours [3]. However, 
viral shedding appears to be prolonged up to several weeks after the symptoms are 
resolved, especially in persons with impaired immunity where persistent infection 
often occur by reinfection [5, 6]. More importantly, illness among the elderly and 
immunocompromised patient can be fatal due to the severe dehydration. The main 
transmission route for noroviruses is by fecal-oral, through the contaminated food, 
water or surfaces especially [1, 7]. Consumption of contaminated fresh produce 
food such as salads, fruits and sandwiches that requires no prior heating have also 
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been linked as a possible source of food-borne infections [8]. Furthermore, a high 
concentration of norovirus was also found within the gastrointestinal tissue of 
contaminated bivalves such as oysters and mussels that are filter feeders. Therefore, 
these contaminated bivalves are also considered as another important foodborne 
source of norovirus infection [9]. In addition, airborne transmission that involves 
the aerosolized vomit from an infected person has also been demonstrated [10, 11]. 
These findings are supported by the low infectious dose required for norovirus 
infection; less than 10 viral particles are sufficient enough to establish infection 
with Norwalk virus [12]. First described as Norwalk virus, which was responsible 
for a gastroenteritis outbreak at a school in Norwalk, Ohio US, in 1968 [13], human 
noroviruses (HuNv) are today recognized as the leading cause of viral gastro-
enteritis infections in human population. The United States Centre for Disease 
Control and Prevention (CDC) has estimated that noroviruses are responsible for 
at least 23 million cases of food borne illness each year in the United States with 
approximately 50 thousands hospitalization and 300 death [4, 14]. However, in 
one of the reviews which involves a period of study from 1996 to 2007, it is esti-
mated to be nearly 110,000 hospitalization per epidemic years with the cost of 
approximately 500 million US dollar per year [15]. The recorded surveillance data 
from the Food Borne Viruses in Europe Network also indicates that more than 85% 
of viral gastroenteritis outbreaks that occurred between 1995 and 2000 could be 
attributed to these viruses [4, 16]. The cost to the United Kingdom National Health 
Service (NHS) in England and Wales as a direct result of the outbreaks occurring in 
hospitals has been estimated to be approximately 115 million pounds in 2002–2003 
[17]. However, due to the acute nature of the infection, it is difficult to identify all 
the norovirus infection cases and therefore the real cost can be considered higher. 
Furthermore, the global impact of gastroenteritis caused by HuNv is hard to be 
estimated since most of the annually 3.5 to 5 million deaths are from developing 
world with inadequate healthcare, surveillance and diagnostic systems [1]. There is 
still no licensed vaccine against norovirus made available. However, there are few 
promising candidates in the pipeline with one already in phase 2 [18]. In addi-
tion, efforts in developing norovirus-specific antiviral drugs are also ongoing. To 
enable these efforts, our fundamental knowledge on norovirus biology needs to be 
enhanced especially with regards to norovirus genome replication. This chapter will 
emphasize on subgenomic RNA replication aspect of norovirus particularly focus-
ing on works with MNV.
2. Building of norovirus particle
The first norovirus virion to be observed by immune-electron microscopy was 
Norwalk virus in 1972 by Albert Kapikian. The virions are icosahedral, with a diam-
eter ranging from 27 to 39 nm and a buoyant density of 1.36 ± 0.04 g/cm3 [4, 13, 19]. 
The virus’s capsids are composed of 180 copies of a major protein VP1 (formed into 
90 dimers) and one or two copies of the minor capsid protein VP2 [20, 21]. Studies 
using Norwalk virus-like particles (VLPs) revealed that the major protein VP1 is 
structurally divided into two domains referred to as the ‘shell’ (S) and ‘protruding’ 
(P) domains, with the P domain being further divided into P1 and P2 subdomains 
[21]. The inner S domain sub-units interact each other to form a continuous ‘shell’ 
structure for capsid while the P domain emanates from the S domain surface 
and forming cup-like structure. Furthermore, the outer P2 subdomain has been 
recognized as the most variable region of the calicivirus capsid and the region 
that determines the species-specific binding of these viruses to the respective cell 
receptor [22, 23]. Molecularly, norovirus particle capsid encloses the viral genome, 
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a positive-sense single stranded RNA molecule of about 7.4 to 8.3 kb in size. The 
genome has a virus encoded protein covalently linked to the 5′ end (VPg) and a 
poly A tail at the 3′ end (Figure 1). This genomic RNA (G RNA) encodes three open 
reading frames (ORFs) flanked by two short untranslated regions (UTRs) and 
with a small degree of overlap at the 5′ and 3′ junctions between ORF1 and ORF2 
[24, 25]. In addition, within the Norovirus genus, only murine norovirus (MNV) 
contains a fourth alternative open reading frame (ORF4) which overlaps ORF2 in 
a + 1 frameshift.
3. The norovirus life cycle
Like all viruses, the life cycle of noroviruses begins with the attachment of 
the viral particles to their specific receptor on the membrane of the host cell. 
Susceptibility to norovirus infections in humans, specifically Norwalk virus, is 
associated with ABO histo-blood group antigens (HBGA) and individual secre-
tor status [26]. HBGA are carbohydrates found on the surface of gut epithelial 
cells [4, 20, 27]. These carbohydrate molecules are involved in the attachment of 
noroviruses but are unlikely to be the main receptor as co-receptor may also be 
involved [27]. In addition, the secretor status of individuals also determines the 
susceptibility to norovirus infections [28]. Individuals who are non-secretors of H 
type 1 were found to be resistant to norovirus infections due to a mutation in the 
α-(1,2)-fucosyltransferase (FUT2) gene, involved in the production of H-type 1 
antigen in saliva and mucosa [29]. Study using murine macrophages which support 
the propagation of the MNV had found that terminal sialic acid moieties present on 
gangliosides can act as a receptor for MNV attachment [30]. However, MNV entry 
into permissive cells has been shown to be pH independent [31]. Relatively recently, 
genome-wide CRISPR screens have identified CD300lf as the receptor for MNV 
attachment to host cells [32]. CD300lf is a type I integral membrane protein with a 
single extracellular Ig-like domain. CD300lf is part of a larger family of CD300 mol-
ecules that function as cell death sensors, as they recognize phospholipids typically 
found on the inner leaflet of cells [33]. After a successful attachment, the norovirus 
particles are believed to get internalized via endocytosis mechanisms such as choles-
terol- and dynamin-dependent [34, 35]. At this stage, the viral genome is released 
from the capsid and translocated to the endosomal membrane in order to enter the 
host cell cytoplasm. However, relatively little is known about detailed mechanisms 
of norovirus entry into cell’s cytoplasm to date.
Figure 1. 
Diagrammatic representation of the norovirus genome. The length of the genomic RNA (G RNA) is 
approximately 7.3 to 8.3 kb with subgenomic RNA (SG RNA) about 2.4 kb. The genome normally contains 
three ORFs with an additional ORF4 in MNV. ORF1 is translated into a large polyprotein which is post-
translationally cleaved into non-structural proteins (NS1-NS7) at the position indicated. These NS proteins 
have alternative nomenclature (indicated in the diagram). ORF2 and ORF3 (and ORF4 of MNV) are thought 
to be translated from the SG RNA template and produce structural proteins; the major capsid (VP1) and 
minor capsid (VP2) protein.
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After entry of the positive sense viral genome into the host cell cytoplasm, 
it can immediately act as mRNA for protein synthesis. The subsequent event of 
norovirus life cyle is a pioneer round of viral proteins translation from the positive 
strand viral genomic RNA. The norovirus VPg (viral protein genome link) protein 
is a 13–15 kDa non-structural protein covalently linked to the 5′ end of the viral 
genomic (G RNA) and subgenomic RNA (SG RNA) and acts as a cap substitute 
(Figure 1). The VPg protein recruits host cells translation initiation factors in 
initiating the translation process to produce viral proteins [36, 37]. This mechanism 
is a unique strategy employed by noroviruses to ensure the preferential translation 
of their RNA over host cell mRNA which possess a classical 5′ cap structure. In fact, 
all caliciviruses use this translational strategy since their 5’UTR is relatively short 
(only 5 nucleotides in MNV) compared to the closely related picornavirus genome 
which contains a much longer 5’UTR. Even though the picornavirus genome also 
possesses a VPg at the 5’end, this smaller protein (~22 amino acids) does not have 
any sequence homology with the calicivirus VPg and is not involved in picornavirus 
translation. Indeed, picornavirus translation is driven by the presence of an internal 
ribosomal entry site (IRES) structure within its 5’UTR [38]. Translation of the first 
open reading frame of noroviruses typically yields a large polyprotein, representing 
the non-structural proteins. This large polyprotein is subjected to further process-
ing by the virus encoded 3C-like (3CL) protease at five specific protease cleavage 
sites yielding six mature forms of the non-structural proteins [39, 40]. Sosnovtsev 
et al. have demonstrated that the proteolytic processing of MNV non-structural 
proteins in an in vitro system closely correlates to the products observed in infected 
RAW264.7 cells [25]. Uncleaved precursor proteins like NS6/NS7 (Pro-Pol) and 
NS1/NS2 can also be detected [25]. However, unlike the FCV protease and poly-
merase that functions as a fusion protein called p76 in infected cells, these proteins 
in noroviruses must be separated in order to be functionally active [25, 41].
The NS1/2 protein is the first non-structural protein in noroviruses (Figure 1) 
and is predicted to have a similar function to the picornavirus 2B protein, which 
is involved in membrane rearrangement and results in a modification of mem-
brane permeability [42]. The enterovirus 2B protein which is a member of the 
Picornaviridae family is localized to the endoplasmic reticulum (ER) and the Golgi 
complex, reduces ER and Golgi complex calcium ion levels, and further inhibits 
protein trafficking through the Golgi complex [43]. Studies using Norwalk virus 
revealed that expression of the NS1/2 protein, also referred to as the N-Term 
protein, leads to Golgi disassembly, indicating a potential role for this protein in 
replication complex formation [42, 44].
The norovirus NS3 protein is a nucleotide triphosphatase (NTPase) (Figure 1). A 
study using a human norovirus (Southampton virus) showed that NS3 has NTPase 
activity that functions to hydrolyse nucleotide triphosphate [45]. In MNV infected 
cells, the NS3 has been shown to associate with the viral replication complex [46]. 
In addition, the equivalent protein in FCV called p39, was found to co-localize with 
viral replication complexes suggesting a possible role in replication [41, 47].
Little is known about the NS4 protein. However, it is thought that NS4 may 
play a role in tissue culture adaptation of MNV since repeated passage of MNV-1 in 
RAW264.7 cells give rise to attenuated viruses in part caused by sequence changes in 
NS4 [48]. Furthermore, NS4 is also thought to recruit VPg to membranous replica-
tion complexes during replication [46]. Targeted mutations in poliovirus 3A, the 
NS4 equivalent, resulted in viruses defective in RNA synthesis [49] indicating that 
by analogy, the norovirus NS4 may also contribute to viral RNA synthesis.
The NS5 encodes the viral VPg protein that plays a multifunctional role in the 
viral life cycle. The main role of VPg has been identified to be in translation initia-
tion. This 13–15 kDa protein is covalently linked to the 5′ end of the G RNA and 
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SG RNA of caliciviruses [50]. VPg has been shown to be essential for viral RNA 
infectivity as treatment of viral RNA with proteinase K rendered the viral RNA 
non-infectious [51]. In vitro translation and infectivity of RNA are also abolished 
upon the removal of FCV and MNV VPg from viral RNA [50, 52]. However, in vitro 
transcribed capped FCV and MNV RNA generated from cDNA clone were infec-
tious when transfected into cells [53, 54]. These observations indicate that the VPg 
plays a role as a cap substitute during the typical mRNA translation process. Using 
in vitro assays, MNV, FCV and Lordsdale virus VPg have been shown to bind the 
cap-binding eIF4F component, eIF4E [37, 52, 55]. Glutathione S-transferase (GST) 
pulldowns using Norwalk virus VPg demonstrated that other eIF4F components 
such as the eIF4A helicase and the scaffold protein eIF4G also associate with the 
translation complex [36]. Although both the FCV and MNV VPg proteins bind to 
eIF4E, only this interaction in FCV is essential as inhibition of eIF4E activity was 
found to severely affect FCV VPg linked RNA [37]. The same inhibition in MNV 
did not affect in vitro translation of MNV VPg linked RNA [52]. Differences were 
also observed in the requirement for eIF4A in vitro, where an increased require-
ment of MNV translation for eIF4A had been demonstrated [52]. Encoded by NS5 
in the ORF 1 of the viral G RNA, the calicivirus VPg protein has also been shown to 
interact with the viral polymerase and capsid protein indicating a multifunctional 
role for this protein in the calicivirus life cycle [56].
The NS6 encodes the viral 3C-like protease and is thought to play a role in inhibi-
tion of cellular protein synthesis in infected cells. In vitro studies using recombinant 
norovirus 3CLpro demonstrated that it cleaved polyA binding protein (PABP) 
[57] and the eukaryotic initiation factor eIF4G [58], both of which are required 
in mRNA translation of host cells. In FCV, the protease is present only in its active 
state when fused to the polymerase. The calicivirus 3C-like protease is released from 
the ORF1 polyprotein by autocatalytic cleavage, subsequently cleaving the other 
proteins in ORF1 with high specificity [41].
The NS7 protein, located at the C-terminus the norovirus ORF 1, encodes the 
RNA-dependent RNA polymerase (RdRp), which is a key enzyme in viral replica-
tion. This protein will be elaborated further in the subsequent subsection of this 
chapter because it plays a major role in viral G RNA and SG RNA replication.
The ORF2 and ORF3 of noroviruses code the structural proteins VP1 and VP2 
respectively. Both of these proteins are expressed from the viral VPg-linked SG RNA 
that is 3′ co-terminal with the G RNA (Figure 1). However, in lagoviruses, sapovi-
ruses and neboviruses, the capsid protein may also be produced from the G RNA 
as the capsid genes for these viruses are in frame with ORF1 giving rise to a poly-
protein that contains both the non-structural proteins and the major capsid protein 
[59, 60]. ORF2 of norovirus encodes the 58.9 kDa major capsid protein (VP1) and 
ORF3 encodes the 22.1 kDa minor capsid protein (VP2) [61]. The expression of VP1 
protein with or without co-expression of VP2 allows dimer formation that can be 
further assembled to produce VLPs in the absence of RNA genome [62–64]. Since 
the HuNv is currently not efficiently propagated in tissue culture, VLPs have been 
used to study a variety of virus-host interactions as they are morphologically and 
antigenically indistinguishable from real virus particles [4]. In FCV, the capsid 
protein contains a leader peptide (leader capsid or LC) at its N terminus that is 
cleaved by p76 to give rise to the mature capsid protein VP1. The VP2 protein has 
been shown to stabilize and protect VLPs from proteolytic degradation when this 
protein is co-expressed with VP1 in the baculovirus system [65]. The very basic 
character of VP2 suggests an interaction with nucleic acid and it may contribute to 
the encapsidation of the viral RNA. However, this hypothesis has yet to be exam-
ined and confirmed. Furthermore, at least for FCV, the VP2 protein is essential for 
the production of infectious particles and for virus replication [66]. In addition to 
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the ORF2 and ORF3, there is another alternative ORF, namely ORF4, which was 
found in MNV, overlapping with the VP1 coding region and encoding the virulence 
factor 1 protein (VF1) [67]. This VF1 protein has been demonstrated to play a role 
in infection and virulence in vivo. Infection of STAT1−/− mice with a mutant virus 
lacking the ability to express ORF4 resulted in a delayed onset of clinical signs 
compared with WT virus infected mice. Using a reverse genetics system, VF1 has 
been shown to function as a classical viral accessory protein that is not required for 
replication in tissue culture [67].
The pioneer round of viral proteins production is proceeded with G and SG 
RNA replication once the viral replication-related proteins are made available in 
the infected cell’s cytoplasm. This particular process will be further elaborated in 
separate section below. When all the viral proteins become available and the replica-
tion has occurred, the viral RNA progeny is then packaged into viral particles. As 
mentioned earlier, the VP2 protein may contribute to this event. The mechanism 
of calicivirus encapsidation has yet to be studied in great detail. Present evidence 
suggests that the SG RNA could be encapsidated separately in the case of RHDV 
as well as in FCV [68, 69]. However, little is known about the mechanisms of 
viral release, but since norovirus infections induce apoptosis, it is speculated that 
apoptosis-induced membrane collapse releases the virus particles from the infected 
cells [70–72].
4. The norovirus genome replication
Once the translation of the norovirus non-structural proteins has begun, their 
presence in infected cells induces the formation of cytoplasmic membrane-bound 
replication complexes, enabling the viral genome replication process to take place 
[73]. These replication complexes, which contain the viral RdRp, viral RNA (single 
and double-stranded intermediates) and other viral enzymes and host cell factors, 
act as a surface or platform for the viral replication. The rearrangement of intracel-
lular membranes (particularly the endoplasmic reticulum and Golgi apparatus) of 
MNV-1 infected RAW264.7 cells has been observed whereby membrane vesicles 
start to appear at twelve hours post infection [74]. The elaboration of norovirus 
genome replication in this chapter will be done interchangeably with the function 
of the central replication enzyme, RdRp.
The RdRp, also known as the RNA replicase, is an enzyme that catalyzes the 
synthesis of RNA from RNA templates. This particular virus enzyme is therefore 
distinct from the typical eukaryotic DNA-dependent RNA polymerase that cata-
lyzes transcription of mRNA from a DNA template. All RNA viruses carry an RdRp 
gene in their RNA genome since this viral replication enzyme is pivotal for genome 
replication in infected cells. In addition, the virions of negative strand and double-
stranded genome viruses must contain the RdRp as a ribonucleoprotein component 
since the incoming RNA genome cannot be translated or copied directly by the 
cellular machinery. The first viral RdRp was discovered in the early 1960’s from 
poliovirus (PV). The poliovirus RNA polymerase (PV3D) is one of the best-studied 
viral RdRp and is often used as a reference for other newly identified RdRps. Studies 
including structural, RNA binding, nucleoside triphosphate (NTP) binding, polym-
erization of nucleotides, RNA strand displacement, and interactions with other 
viral proteins have been thoroughly investigated for PV3D [75–78].
Most of our understanding on the properties of viral RdRps comes from in vitro 
studies using purified proteins. This includes the initiation of RNA synthesis 
that is driven by RdRps. The mechanism of RNA synthesis initiation is divergent 
between RdRps from different viruses. However, common mechanisms have been 
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determined to be the de novo and the primer-dependent initiation. The presence 
of an RdRp, an RNA template, the initiating NTP (NTPi) and a second NTP is 
required in order to achieve the de novo initiation. The initiating NTPi, sometimes 
known as the one-nucleotide primer provides the 3′-hydroxyl (OH) group for the 
addition of the next nucleotide and elongation usually follows immediately [79]. 
The de novo initiation normally occurs at 3’end of viral RNA. However, internal ini-
tiation may also appear as in the case of SG RNA synthesis. For RdRps that employ a 
primer for primer-dependent initiation, the primer can be a protein-linked oligo-
nucleotide (i.e; VPg-pU-pU, as in the case of picornavirus) or oligonucleotides with 
a 5’end capped structure that is cleaved from the cellular mRNA in a process called 
‘cap-snatching’ (as used by many segmented negative strand RNA viruses such as 
influenza virus) [79]. Some viral RdRps also exhibit the terminal transferase activ-
ity that confers an ability to incorporate NTPs at the 3′ end of viral RNA template. 
RdRps with this property can initiate RNA replication by ‘copy-back’ or ‘template-
primed’ synthesis mechanism. Incorporation of NTPs at the 3′ end of RNA template 
forms a loop structure able to fall back onto the RNA template and eventually serve 
as a primer for the RdRp to carry on with elongation. Terminal transferase activity 
for hepatitis C virus [80], poliovirus [81] and more significantly for HuNv RdRp 
[82] has been reported in vitro whereby the detection of double length RNA as a 
predominant product compared to the template RNA used in the reaction is often 
observed. However, this ‘copy-back’ synthesis by RdRp could theoretically be an 
artifact of in vitro reactions [79].
The RdRp gene of noroviruses is located at the C-terminal of non-structural 
polyprotein. With an approximate size of 57.5 kDa (in MNV), this virally encoded 
non-structural (NS7 in MNV) protein plays a key role in norovirus G RNA and SG 
RNA replication. Generally, the replication of G RNA is achieved through a negative 
sense RNA intermediate which serves as a template for the production of nascent 
positive sense viral G RNA. This general mechanism also applies to the caliciviruses 
where the presence of negative sense G RNA as well as SG RNA has been shown by 
Northern blot analysis during the infection of FCV in tissue culture. Currently, four 
main mechanisms for the initiation of RNA synthesis by recombinant calicivirus 
(including norovirus) RdRps have been demonstrated in vitro. They are: a de novo 
initiation and primer-independent initiation [82–84], back-priming base initiation 
[79, 85, 86] and a protein-primed initiation via VPg nucleotidylylation [84, 87]. 
The biochemical features of bacterially expressed recombinant RdRp noroviruses 
(HuNV and MNV) have been well characterized and in vitro enzymatic activity 
has been described [87–90]. Out of these four established mechanisms however, 
the de novo initiation is the proposed model to be employed by norovirus for the 
synthesis of both the G RNA and SG RNA by direct interaction between viral RdRp 
with its’ VP1 (at the shell domain). A cell-based assay supported this proposed 
model through indirect measurement of 5′-triphosphorylated RNA production by 
the RdRp [91].
5. Production of subgenomic RNA in other viruses relative to norovirus
The genome organization and strategies for gene expression of positive strand 
RNA viruses are diverse. In addition to the occurrence of specific proteolytic 
cleavage sites which mediate the translational processing of the large polyprotein 
and give rise to several mature proteins encoded by one large ORF, many viruses 
often express their downstream ORFs through the transcription and translation of 
a SG RNA. Generally, SG RNAs of positive strand RNA viruses are identical to the 
3′ ends of their parental G RNA. However, they vary in length where the 5′ end of 
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these SG RNAs are in proximity with the start codon of respective ORF. In most 
cases, these viral SG RNAs carry the ORFs that code for proteins required in the 
intermediate and late stages of infection, such as the structural proteins. Animal 
positive stranded RNA viruses that produce SG RNA include the Coronaviridae and 
Arteriviridae family of Nidovirales order, Togaviridae, Nodaviridae, Astrovoridae and 
Caliciviridae families. However, the vast majority of plant viruses have been demon-
strated to produce SG RNAs. These viruses are from the Luteoviridae, Bromoviridae, 
Tombusviridae and Closteroviridae families and the Tobravirus, Carlavirus, 
Tymovirus, Potexvirus, Hordeivirus, Tobamovirus, Sobemovirus and Furovirus genera 
[92]. The mechanism of SG RNA synthesis has been studied in more detail in plant 
viruses than in animal viruses. Therefore, most of our understanding of the mecha-
nisms of how SG RNA synthesis is achieved comes from established models for 
plant viruses.
There are currently two well-characterized and one additional mechanism for 
positive strand RNA virus SG RNA synthesis. The first described mechanism and 
the most widely recognized model is internal initiation, which has been clearly 
demonstrated in studies involving brome mosaic virus (BMV) (Bromoviridae 
family). In this instance the viral RdRp initiates (+) strand SG RNA4 transcription 
internally at a specific promoter region on the full-length (−) strand template of G 
RNA3 [93]. The BMV genome is composed of three positive sense, capped RNAs. 
RNA1 (monicistronic) encodes protein 1a with capping and putative RNA helicase 
activities. RNA2 (monocistronic) encodes protein 2a, a putative RNA-dependent 
RNA polymerase. RNA3 (bicistronic) encodes for two proteins: 3a, which is 
required for cell-to-cell movement, and the capsid protein. The capsid is translated 
from a subgenomic RNA, RNA4 [94]. The transcription of SG RNA4 is driven by 
the interaction of the replicase with the promoter sequence which functions on the 
minus-strand RNA3 and is situated directly upstream of the SG RNA4 initiation 
site. Initial studies showed that at least four key nucleotides in the core promoter 
are recognized by the viral replicase prior to the initiation of SG RNA4 synthesis 
highlighting the importance of primary RNA sequences in the SG RNA promoter 
[95]. Subsequent studies however, showed that a short RNA hairpin in the core pro-
moter serves as the replicase binding site and that some of the key nucleotides help 
to form a stable hairpin structure in this core promoter region [96, 97]. Eventually, 
Sivakumaran et al. [98] concluded that the key nucleotides in the core promoter as 
reported previously act by directing replicase recognition. Whilst the formation of 
stem-loop is only required at a step after the binding of replicase to this promoter 
region [98].
Animal viruses such as Sindbis virus (alphavirus) and Rubella virus (rubivi-
rus) from the Togaviridae family have also been extensively studied as models for 
internal initiation of SG RNA synthesis [99]. The Sindbis virus genome consists of 
an 11.7 kb positive strand RNA which is capped at its 5’end and is polyadenylated at 
the 3’end (Figure 2) [100]. The four alphavirus non-structural proteins (nsP1234; 
which involve in catalysis the genome replication) are translated from the 5′ ORF, 
and are synthesized as a polyprotein, which are subsequently processed into indi-
vidual proteins. The 3’ ORF codes for the three structural proteins; capsid (C) and 
envelope proteins (E123) are translated from the SG RNA. Synthesis of SG RNA 
is mediated via an internal promoter on the (−) strand viral RNA. The minimal 
sequence on the (−) strand RNA which has SG promoter activity in vivo corre-
sponds to a region from −19 to +5 on the viral genome, using the initiation nucleo-
tide of the SG RNA (nucleotide 7598 of the viral genome) as +1 [101]. Further 
studies have shown that a longer nucleotide sequence from −98 to +14 is required to 
obtain a more efficient SG RNA transcription [102]. On the other hand, the in vitro 
synthesis of SG RNA using a cell-free system proved that the internal initiation 
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mechanism is employed, where the critical component which is a minus-strand 
promoter-template corresponding to the region of the Sindbis virus genome from 
nucleotide 7441 to nucleotide 7772 (−157 to +175 relative to the SG RNA transcrip-
tion initiation site at nucleotide 7598) [103]. Therefore, it could be concluded that 
sometimes, the minimal promoter requirements in vitro are generally insufficient 
in vivo. Additional sequences are required in vivo to allow the replicase complex to 
come into proximity with the core promoter. Such requirements may not be critical 
in highly purified in vitro systems [92].
The second mechanism for SG RNA synthesis is termed as a premature termina-
tion and occurs during the (−) strand template synthesis from the full length (+) 
strand G RNA. This premature termination gives rise to a subgenomic-length (−) 
strand RNA that then serves as a template for subsequent end-to-end (+) strand 
SG RNA synthesis. The generation of this smaller subgenomic-length (−) strand 
complementary RNA is due to the early disengagement of the RdRp when it reaches 
a RNA secondary structure in the (+) strand viral genome template (known as a 
termination signal). These RNA structures are normally comprised of either local 
secondary structures or long-distance RNA interactions that form a highly ordered 
structure. The plant virus tomato bushy stunt virus (TBSV), the prototype member 
of the Tombusviridae family, provides the best-studied and complex example for 
premature during SG RNA synthesis. This virus was first isolated from tomato 
plants in 1935 where it causes stunting of growth, leaf mottling, and deformed 
or absent fruit. The size of the (+) strand TBSV genome is 4.8 kb in length and it 
contains five functional ORFs [104]. The 5′-terminal ORF encodes p33 and a read 
through product p92. These two proteins are the only viral proteins required for 
viral RNA synthesis, and both are translated directly from the viral G RNA [105]. 
The translation of the other three proteins (p41, p22 and p19) is supported by the 
production of two SG RNAs. The coat protein, p41 is translated from the SG RNA1 
while the p22 (cell to cell movement) and the p19 (suppression of host defense 
mechanism) proteins are translated from SG RNA2 via overlapping ORFs [106]. The 
employment of a premature termination mechanism for TBSV SG RNAs synthesis is 
mediated by the formation of two different sets of long-distance RNA–RNA interac-
tions, both present in the positive strand genomic RNA. The first one involves an 
RNA sequence located immediately 5′ to the site of transcriptional initiation of 
SG RNA1 called receptor sequence (RS1) and partner segments positioned ~1000 
nucleotides upstream called activator sequence (AS1) which mediate the transcrip-
tion of SG RNA1 [107]. The second interaction which mediates the synthesis of SG 
RNA2 involves the distal element (DE) which is located ~1100 nucleotides upstream 
from the initiation site of SG RNA2 transcription. This DE must base pair with a 
Figure 2. 
Schematic representations of alphavirus virus genome organization. The genomic RNA (G RNA) has a methyl 
guanine cap structure (m7G) at the 5’end and a polyadenylated tail (an) at the 3’end. The non-structural 
proteins are translated from non-structural protein ORF from the G RNA while the structural proteins are 
translated from SG 26S RNA that is transcribed from a replication intermediate negative strand RNA and the 
26S subgenomic RNA promoter. The figure is adapted from Spurgers and Glass [100].
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portion of the core element (CE) located just 5′ to the SG RNA2 initiation site [108]. 
Furthermore, another long distance interaction between AS2/RS2 has been identi-
fied and is essential (along with DE/CE) for regulating the production of SG RNA2 
[104]. It is possible that the AS/RS structure could be bound by a protein factor 
that stabilizes them, therefore facilitating the premature termination step of RNA 
copying by the viral replicase. In another plant virus that utilizes the premature 
termination mechanism for SG RNA synthesis, a more complex RNA–RNA interac-
tion has been demonstrated. In red clover necrotic mosaic virus (RCNMV), an AS/
RS-like interaction is also essential for SG RNA transcription from RNA1. However, 
this interaction forms in trans between the two G RNA segments called RNA1 and 
RNA2 [109].
In addition to the two well-characterized SG RNA synthesis mechanisms 
described above, there is another more unusual mechanism employed by members 
of the families Coronaviridae and Arteriviridae from the Nidovirales order, known 
as discontinuous transcription. Viruses from these families contain a very large 
positive sense RNA genome (between 15 and 31 kb) and produce a nested set of 
seven 3′ co-terminal SG RNAs. Uniquely, all these SG RNAs contain a 90 nucleotide 
leader sequence derived from the 5′ end of the G RNA. These SG RNAs are synthe-
sized from non-contiguous sequences at the 5′ and 3′ ends, respectively, of the viral 
(+) strand genome. The leader and body of SG RNAs are separated by a conserved 
sequence found in the intergenic regions (IG) that can be found at the 3’end of the 
leader and at the 5′ end of the SG RNA body. Discontinuous transcription occurs 
during (−) strand RNA synthesis. Most of the (+) strand RNA template is not 
copied, perhaps because it loops out as the polymerase completes the synthesis of 
leader RNA. The resulting (−) strand RNAs with leader sequences at the 3′ ends, are 
then copied to form the various length SG RNAs.
6.  The norovirus subgenomic RNA transcript and its translational 
products
All noroviruses produce a SG RNA during their replication cycle in infected 
cells. This SG RNA is 3′ co-terminal with the full-length G RNA, has VPg linked at 
the 5′ end and carries a poly-A tail at the 3′ end. Typically, the SG RNAs of norovi-
ruses contains ORF2 and ORF3 (and ORF4 in the case of MNV and some sapovi-
ruses) which code for viral structural proteins (VP1 and VP2). The production of 
a SG RNA message may act to delay the production of structural proteins until the 
initial rounds of viral replication have taken place. Both positive and negative sense 
SG RNA intermediates (~2.5 kb in length) can be detected by northern blot analysis 
of purified FCV replication complexes [73].
Following the transcription of MNV SG RNA, the expression of this messenger 
transcript via VPg-dependent translation initiation is achieved as described for 
the G RNA. The 5′ proximal ORF2, which encodes the major capsid protein is first 
translated when the scanning ribosomal complex encounters the first AUG codon, 
a typical strategy for translation. However, in viruses with polycistronic SG RNAs, 
the translation of their 3′ terminal ORF is not as efficient as the preceding ORF. 
Therefore, many viruses employ several strategies to provide sufficient access for 
ribosomes to downstream ORFs. These strategies include leaky scanning of 40S 
subunits past the start codon of the first ORF, the possession of intercistronic 
internal ribosome entry signal, programmed ribosomal frame-shifting during 
elongation and stop codon suppression at the termination step [110]. All norovi-
ruses SG RNA are bicistronic messages. The translation of the 3′ proximal ORF in 
this case is achieved by a unique mechanism called termination reinitiation. In this 
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mechanism, a proportion of the 40S ribosomal subunit remains associated with the 
mRNA following the translational termination at the preceding stop codon. This 
enables reinitiation at the AUG of a downstream ORF, which is in close proximity. 
This characteristic has been observed for different caliciviruses where the initiation 
codon of VP2 (overlapped with VP1) is only 2 nucleotides away from the stop codon 
of VP1 for RHDV. Meanwhile for Norwalk virus, FCV and MNV, the start codon of 
VP2 is overlapped with the stop codon of VP1 [111]. Other than the close proximity 
between the stop and start codon, the efficiency of termination-reinitiation transla-
tion is also determined by a stretch of 70 to 80 nucleotides upstream of the stop-
start window which facilitates the transit of the ribosome through the stop codon of 
VP1. This region of conserved sequence is termed TURBS (termination upstream 
ribosome binding site motif). The translation of VP2 from the FCV, RHDV and 
MNV SG RNA is dependent on this TURBS region, which is located immediately 
upstream of the VP1 stop codon [110–112]. The TURBS contain two important 
sequences; the 5′ sequence (termed as Motif 1) is proposed to function in binding 
the 18S rRNA (through complementary sequence) whilst the other sequence is 
thought to be important in tethering the ribosome to enable translation of VP2 at 
the correct site [110, 113]. Alternatively, the TURBS may also act by interacting 
with eIF3 or eIF3/40S ribosome complexes preventing disassembly of the ribosome 
following VP1 translation termination. This alternative mechanism is supported by 
the fact that purified eIF3 is able to stimulate translational re-initiation [114].
7. The replication of norovirus subgenomic RNA
The presence of SG RNA of norovirus in infected cells is often used as indicator 
for active viral genome replication. Importantly, the mechanism that is used by 
noroviruses to achieve their SG RNA transcription is poorly understood until very 
relatively recently. Initial evidence from in vitro studies using RHDV RNA tran-
scripts suggests that the internal initiation mechanism is employed [115]. In vitro 
promoter mapping analysis using a panel of nested negative sense RNA templates 
that included the region before the start of ORF2, demonstrated that the RHDV 
RdRp requires 60 bases upstream of the start of the SG RNA transcription start site 
in order to produce SG RNA [115]. At this point, this finding indicates the existence 
of a promoter site upstream of the SG RNA start site that enables the binding of 
RdRp and internally initiates the SG RNA synthesis on the negative strand G RNA. 
Subsequently, in another study involving MNV, mutational analysis of an evolu-
tionarily conserved RNA stem loop structures using the available reverse genetics 
system has highlighted that the stability of a specific RNA structure is critical for 
MNV replication [116]. This specific RNA stem loop structure was consistently 
detected exactly 6 nucleotides upstream of the SG RNA start site in all caliciviruses 
on both the positive (SL5018) and negative strand RNA (SLa5045) (Figure 3) [116]. 
This observation implies that these RNA secondary structures may accommodate 
a functional role in viral SG RNA synthesis. Furthermore, the stem loop structure 
was generally found to be more stable on the negative strand genome (SLa5045) 
than the positive strand. Thus, such a structure was initially hypothesized to play 
a role as the putative SG RNA promoter for the synthesis of MNV SG RNA via 
internal initiation mechanism. It is also possible that after internal initiation has 
occurred to produce newly synthesized VPg-linked SG RNA, this RNA may then be 
picked up by the viral replication machinery and replicated in a similar manner to 
the G RNA, effectively producing a negative strand SG RNA molecule.
As reported by Simmonds et al. [116], a mutant cDNA clone containing a series 
of non-coding mutations called m53 that destabilized the RNA structure was 
Norovirus
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generated. These mutations were designed to destabilize the stem loop structure 
by weakening the base pairing without affecting the NS7 coding sequence. This 
mutated cDNA clone was used in the DNA-based reverse genetics system and 
reported to cause a lethal phenotype effect, whereby no infectious virus can be 
detected by TCID50 in the recoveries. However, by compensating the initial m53 
mutations to restore the base pairing within the stem loop structure (called m53r), 
a viable virus was recovered with a titer close to that of the wild type virus. This 
series of experiments concluded that RNA stem loop structure is important for viral 
replication and might function as part of the SG RNA promoter. Even though the 
m53 mutation disrupting SLa5045 caused a lethal phenotype, serial “blind” pas-
sage of the recoveries (from the DNA based reverse genetics system) in RAW264.7 
cells often produced viable viruses. Sequence analysis revealed that these viable 
viruses contained two types or classes of mutation. The first class were phenotypic-
revertant viruses where nucleotide changes were identified that resulted in partial 
reformation of the SLa5045 stem loop structure. The ability to isolate phenotypic 
revertant viruses that repaired the defective RNA structure was not unexpected as 
the stem loop structure is predicted to play an important role in viral replication. 
This observation indicates that m53 mutation in the viral genome results in poor 
viral genome replication in tissue culture. Phenotypic-revertant mutations arise in 
tissue culture and those that promote replication are favored and amplified during 
the serial “blind” passage until they become dominant. Another type of mutation 
observed were suppressor mutations, whereby the m53 mutation in the SLa5045 
was still present, but changes outside the stem loop structure, within the NS7 cod-
ing region, were also identified [117]. Further characterization of this suppressor 
mutant viruses in cell culture revealed that they possess a slower growth kinetics, 
lower-level proteins production and lower-level of G RNA and SG RNA transcripts 
synthesis compared to WT virus [117]. More importantly, these data indicate that 
nucleotide changes were responsible for the suppression phenotype rather than any 
amino acid change, suggesting the potential involvement of long-range RNA–RNA 
interactions between SLa5045 and a region ~100 nucleotides upstream of this 
Sla5045 stem loop structure [117]. However, this hypothesis is yet to be proven with 
Figure 3. 
Conserved RNA secondary structures upstream of the subgenomic transcript predicted by Alifold programme 
for the 5 calicivirus genera. The stable small secondary stem loop structure was consistently found 6 nucleotides 
upstream of the MNV SG RNA initiation site. The stem loop is shown in its antisense orientation (SLa5045). 
Gray filled boxes represents the SG RNA start site and black boxes represents the ORF2 initiation codon. The 
unpaired 6 nucleotides sequences between the predicted structure and the subgenomic start site are underlined 
(figure is taken from Simmonds et al. [116]).
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scientific experimental and the current readily available bioinformatics tools are not 
adequate to accurately predict such long range RNA–RNA interaction. On the other 
note, such long range RNA–RNA interactions between promoter regions are well 
established with some sequences being up to ~1500 nucleotides apart e.g. the noda-
virus Flock House virus (FHV) and tombusvirus tomato bushy stunt virus (TBSV) 
have been documented to contain such interactions even though these viruses 
employ a premature termination mechanism for their SG RNA synthesis [118, 119]. 
In the case of MNV however, it is worth to note that this long-range RNA–RNA 
interaction presumably occurs on the negative strand RNA to produce a suppression 
effect on m53 mutation of the SLa5045.
Utilizing the MNV reverse genetics system, virus recoveries using series of 
modified cDNA with additional copy of SLa5045 in cis within the noncoding region 
upstream the capsid gene (SLa5045Dup) showed that only m53r mutation and two 
nucleotide changes at the terminal loop in the second copy stem loop of m53 back-
bone construct (m53/m53r and m53TL-Dis) produced detectable viable virus [117]. 
The other construct namely SLa5045Dup m53/SLa WT + 8, whereby the nucleotide 
spacing of the stem loop and initiation site of the SG RNA was increased from 6 to 8 
nucleotides, failed to produce any viable virus. In addition, total sequence modifica-
tion that retained or totally disrupt the stem structure in the additional SLa5045 
also caused a debilitating effect to the virus [117]. These constructs were designed 
with the aim to introduce a more synonymous mutations since the second copy of 
SLa5045 is located at the noncoding region compared to the first stem loop which 
positioned at the NS7 coding region. Any extensive mutations introduced in the 
first copy of the structure would affect the NS7 coding capacity. These set of data 
demonstrate that the sequence, exact location in the norovirus genome and stability 
of SLa5045 are mandatory for virus replication [117].
Even though the presence of low levels of negative sense SG RNA have been argued 
for the premature termination of negative sense G RNA during elongation by RdRp 
that produces SG-length negative sense RNA transcript (act as template for positive 
sense SG RNA) [73, 120], a more detailed study suggests that norovirus SG RNA 
replication follows the internal initiation mechanism. Employing genetics and bio-
chemical tools, a recent study demonstrates that accurate norovirus SG RNA synthesis 
is depend on a sequence and genotype-specific interaction of the viral RdRp with a 
stem-loop sequence (SLa5045) on the minus-strand RNA [117]. In that study, the 
investigators performed an in vitro RNA synthesis assay involving series of chemically 
synthesized RNA templates containing the SLa5045 sequence (from MNV and human 
GII.4 norovirus) that called proscripts and recombinant MNV RdRp. The outcomes 
of that specific experiment indicate that the norovirus RdRp is capable of recognizing 
the stem loop sequence and subsequently direct the RNA synthesis. Therefore, the 
role of stem loop structure as core promoter for norovirus SG RNA synthesis has been 
established. However, whether there was any direct interaction between the RNA stem 
loop with RdRp remained unclear until a more detailed biochemical study came out 
later in 2015. Using a reversible crosslinking peptide fingerprinting analysis (RCAP) 
in one of the mapping studies, the investigators identified that 17 peptides originating 
from MNV RdRp were associated with RNA proscripts that contained the noroviruses 
SG RNA core promoter sequences (from MNV and HuNv GII.4) [121]. Based on the 
MNV-1 crystal structure, most of these cross-linked peptides are precisely located 
in the central cavity of the enzyme which is critical for RNA synthesis [121]. A more 
detailed mutational and functional analysis also revealed that residues R411 (arginine 
at position 411) and R416 (arginine at position 416) of amino acid sequence in MNV 
RdRp contributed to the binding towards subgenomic promoter hairpin [121]. These 
series of studies concluded that the noroviruses are highly likely employing an internal 
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8. Conclusion
The synthesis of norovirus SG RNA is a clear signal for the existence of genome 
replication since the production of this smaller RNA (that is 3′ co-terminal with 
the full length viral genome) is dependent on efficient genome replication in 
infected cells. Furthermore, the transcription of SG RNA at the middle and lat-
ter stages of infection is also thought to regulate the production of infectious 
virions. Since the capsid proteins of noroviruses are translated from the SG RNA 
messenger, the encapsidation process is initiated once the viral RNA replication 
begins. Investigations on the involvement of functional RNA elements in regulat-
ing the synthesis of the MNV SG RNA were carried out extensively to determine 
the mechanism employed by noroviruses in their genome replication accurately. 
Based on the establised data available recently, now clear that we could confidently 
presume that norovirus follows the internal initiation mechanism for the synthesis 
of SG RNA. The studies also proved the crucial role of small stem loop/hairpin 
structure within the coding region of NS7 in the viral replication.
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